Panagene Inc (046210) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Based on the latest financial reports, Panagene Inc (046210) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.17 Million ≈ $31.29K USD) by net assets (₩77.27 Billion ≈ $52.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Panagene Inc worth for the company's overall valuation and market capitalisation.

Panagene Inc - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Panagene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Panagene Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Panagene Inc ranked by their cash flow conversion efficiency. Explore earnings quality score of Panagene Inc to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
D P Wires Limited NSE:DPWIRES	0.208x
Carmit TA:CRMT	0.031x
Radiopharm Theranostics Ltd AU:RAD	-1.349x
Spinnova Oy HE:SPINN	-0.081x
Live Ventures Inc NASDAQ:LIVE	0.103x
Silver Bear Resources Inc TO:SBR	0.109x
Carbonxt Group Ltd AU:CG1	-0.146x
Tondo Smart Ltd TA:TNDO	-0.341x

Annual Cash Flow Conversion Efficiency for Panagene Inc (2006–2024)

The table below shows the annual cash flow conversion efficiency of Panagene Inc from 2006 to 2024. View today's stock price for Panagene Inc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩76.04 Billion ≈ $51.53 Million	₩346.54 Million ≈ $234.84K	0.005x	+701.91%
2023-12-31	₩63.57 Billion ≈ $43.08 Million	₩36.13 Million ≈ $24.48K	0.001x	-99.46%
2022-12-31	₩31.69 Billion ≈ $21.48 Million	₩3.36 Billion ≈ $2.28 Million	0.106x	-47.35%
2021-12-31	₩29.84 Billion ≈ $20.22 Million	₩6.01 Billion ≈ $4.07 Million	0.201x	+19.31%
2020-12-31	₩25.07 Billion ≈ $16.99 Million	₩4.23 Billion ≈ $2.87 Million	0.169x	+225.83%
2019-12-31	₩20.20 Billion ≈ $13.69 Million	₩1.05 Billion ≈ $709.60K	0.052x	-17.13%
2018-12-31	₩16.30 Billion ≈ $11.05 Million	₩1.02 Billion ≈ $690.98K	0.063x	+158.64%
2017-12-31	₩19.84 Billion ≈ $13.44 Million	₩-2.12 Billion ≈ $-1.43 Million	-0.107x	-100.63%
2016-12-31	₩21.10 Billion ≈ $14.30 Million	₩-1.12 Billion ≈ $-760.05K	-0.053x	-30.35%
2015-12-31	₩8.91 Billion ≈ $6.04 Million	₩-363.21 Million ≈ $-246.14K	-0.041x	-107.56%
2012-12-31	₩8.92 Billion ≈ $6.05 Million	₩4.81 Billion ≈ $3.26 Million	0.539x	+333.48%
2011-12-31	₩15.94 Billion ≈ $10.80 Million	₩-3.68 Billion ≈ $-2.50 Million	-0.231x	-104.70%
2010-12-31	₩16.66 Billion ≈ $11.29 Million	₩-1.88 Billion ≈ $-1.27 Million	-0.113x	+53.02%
2009-12-31	₩17.92 Billion ≈ $12.15 Million	₩-4.31 Billion ≈ $-2.92 Million	-0.240x	-514.69%
2008-12-31	₩25.88 Billion ≈ $17.54 Million	₩1.50 Billion ≈ $1.02 Million	0.058x	-7.83%
2007-12-31	₩34.14 Billion ≈ $23.14 Million	₩2.15 Billion ≈ $1.45 Million	0.063x	+41.98%
2006-12-31	₩30.94 Billion ≈ $20.97 Million	₩1.37 Billion ≈ $928.01K	0.044x	--

About Panagene Inc

KQ:046210 Korea Biotechnology & Medical Research

Market Cap

$24.54 Million

₩36.22 Billion KRW

Market Cap Rank

#24535 Global

#1756 in Korea

Share Price

₩1127.00

Change (1 day)

-3.59%

52-Week Range

₩999.00 - ₩2650.00

All Time High

₩12000.00